UNSPSC 51263500: Adrenergic blocking agent phenethylamines and quinolines

This classification denotes Adrenergic blocking agent drugs made from or based in part on phenethylamines, or quinolines

UNSPSC 51263500 Adrenergic blocking agent phenethylamines and quinolines is a Class code that captures state and local procurement of pharmaceutical products, particularly naloxone and related emergency-response medications, along with associated drug-handling and deactivation systems. The code reflects a mix of public-health and substance-abuse-response initiatives driven by county health departments and state health agencies. Issuing bodies include county community health services (such as Seminole County, Florida) and state health commissions (such as the Texas Health and Human Services Commission), though the recent-opportunities block shows limited activity under this specific code—the nominal pharmaceutical classification does not fully align with the actual scope of recent solicitations, which emphasize operational procurement of naloxone and drug deactivation systems rather than the abstract chemical family the code nominally describes.

Recent activity centers in the Southeast and South. Seminole County, Florida posted an IFB (Solicitation IFB60459723LAS, response due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the procurement included workers' compensation and commercial general liability insurance requirements, drug-free workplace certification, and E-Verify compliance, with potential FEMA funding. The Texas Health and Human Services Commission issued an RFI (HHS0017013, response deadline April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription fulfillment and therapeutic pharmacy initiatives outside traditional pharmacy benefit manager and group purchasing organization channels. The code shows sparse recent activity; practitioners should monitor state health departments and county public-health procurement channels for evolving demand in emergency-response pharmaceutical supply and pharmacy-benefit restructuring initiatives.